Skip Navigation LinksCOVID Study Site > Review > Investigation > Treatment Tracker
Skip Navigation Links
Your Diagram TitleCovid 19 Treatments → Phase 1: 12Covid 19 Treatments → Preclincal: 10Covid 19 Treatments → Phase 3: 8Phase 3 → Gilead Remdesivir: 4Phase 3 → Roivant: 4Gilead Remdesivir → USA: 4Roivant → Switzerland: 4Covid 19 Treatments → Phase 2: 3Phase 2 → Athersys: 3Athersys → USA: 3Phase 1 → Ascletis Pharma Ganovo: 2Phase 1 → Celularity CYNK-001: 2Phase 1 → I-Mab: 2Ascletis Pharma Ganovo → China: 2Celularity CYNK-001 → USA: 2I-Mab → China: 2Phase 1 → Merck and Emory EIDD-2801: 2Phase 1 → Eli Lilly AbCellera: 2Phase 1 → Regeneron: 2Merck and Emory EIDD-2801 → USA: 2Eli Lilly AbCellera → USA: 2Regeneron → USA: 2Preclincal → SAB and CSL Behring: 1Preclincal → AlloVir: 1Preclincal → Amgen and Adaptive: 1Preclincal → AstraZeneca and Vanderbilt: 1Preclincal → Celltrion: 1Preclincal → Grifols: 1Preclincal → Neurimmune and Ethris: 1Preclincal → Pfizer: 1Preclincal → Takeda,CSL Behring,Biotest,BPL,LFB,Octapharma: 1Preclincal → Vir Biotechnology: 1SAB and CSL Behring → USA: 1AlloVir → USA: 1Amgen and Adaptive → USA: 1AstraZeneca and Vanderbilt → USA: 1Celltrion → South Korea: 1Grifols → Spain: 1Neurimmune and Ethris → Germany: 1Pfizer → USA: 1Takeda,CSL Behring,Biotest,BPL,LFB,Octapharma → Japan: 1Vir Biotechnology → USA: 1Covid 19 Treatments: 33Covid 19 TreatmentsCelularity CYNK-001: 2Celularity CYNK-001Celltrion: 1CelltrionGrifols: 1GrifolsNeurimmune and Ethris: 1Neurimmune and EthrisTakeda,CSL Behring,Biotest,BPL,LFB,Octapharma: 1Takeda,CSL Behring,Biotest,BPL,LFB,OctapharmaPhase 3: 8Phase 3Phase 2: 3Phase 2Phase 1: 12Phase 1Preclincal: 10PreclincalGilead Remdesivir: 4Gilead RemdesivirAthersys: 3AthersysRoivant: 4RoivantMerck and Emory EIDD-2801: 2Merck and Emory EIDD-2801Eli Lilly AbCellera: 2Eli Lilly AbCelleraRegeneron: 2RegeneronSAB and CSL Behring: 1SAB and CSL BehringAlloVir: 1AlloVirAmgen and Adaptive: 1Amgen and AdaptiveAstraZeneca and Vanderbilt: 1AstraZeneca and VanderbiltPfizer: 1PfizerVir Biotechnology: 1Vir BiotechnologyI-Mab: 2I-MabAscletis Pharma Ganovo: 2Ascletis Pharma GanovoJapan: 1JapanGermany: 1GermanySpain: 1SpainSouth Korea: 1South KoreaChina: 4ChinaSwitzerland: 4SwitzerlandUSA: 21USA